The ECS Affects Most Disease That Has an Inflammation Related Component
CLICK ON UNDERLINED TEXT FOR MORE INFORAMTION
The ECS is a homeostatic regulator of inflammation and has been shown to play a key role in affecting various diseases associated with inflammation.
Various diseases that the ECS has been shown to have an impact on in clinical trials range from epilepsy to autism. FDA trials are currently underway to bring phytocannabinoids to market that affect said diseases as well as: